Explore
Validate
LearnARP32473_P050
antibody from Aviva Systems Biology
Targeting: TAF1
BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250
Western blot
Chromatin ImmunoprecipitationAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ARP32473_P050 - Provider product page
- Provider
- Aviva Systems Biology
- Proper citation
- Aviva Systems Biology Cat#ARP32473_P050, RRID:AB_450550
- Product name
- TAF1 antibody - C-terminal region (ARP32473_P050)
- Antibody type
- Polyclonal
- Antigen
- The immunogen is a synthetic peptide directed towards the C terminal region of human TAF1
- Description
- Affinity Purified
- Reactivity
- Human, Mouse, Rat, Bovine, Canine, Horse, Porcine, Rabbit
- Host
- Rabbit
- Vial size
- 100 μl
- Concentration
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
- Storage
- For short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles.
No comments: Submit comment
Supportive validation
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- WB Suggested Anti-TAF1Antibody Titration: 0.2-1µg/ml. ELISA Titer: 1:62500Positive Control: Daudi cell lysateTAF1 is strongly supported by BioGPS gene expression data to be expressed in Human Daudi cells
Supportive validation
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- Immunohistochemistry staining of Human Kidney with Anti-TAF1 antibody
- Sample type
- Human Kidney
- Validation comment
- This location is supported by literature
- Primary Ab dilution
- 4.0-8.1125
- Secondary Ab
- Secondary Ab
- Secondary Ab dilution
- 0.5ug/mL 0.2ug/mL
- Protocol
- Protocol
